1H-Pyrazolo[3,4-c]pyridine - CAS 271-47-6
Catalog: |
BB019483 |
Product Name: |
1H-Pyrazolo[3,4-c]pyridine |
CAS: |
271-47-6 |
Synonyms: |
1H-pyrazolo[3,4-c]pyridine |
IUPAC Name: | 1H-pyrazolo[3,4-c]pyridine |
Description: | 1H-Pyrazolo[3,4-c]pyridine (CAS# 271-47-6) is a useful research chemical for organic synthesis and other chemical processes. |
Molecular Weight: | 119.12 |
Molecular Formula: | C6H5N3 |
Canonical SMILES: | C1=CN=CC2=C1C=NN2 |
InChI: | InChI=1S/C6H5N3/c1-2-7-4-6-5(1)3-8-9-6/h1-4H,(H,8,9) |
InChI Key: | KNYHISBJRQVMAZ-UHFFFAOYSA-N |
Boiling Point: | 318.8 °C at 760 mmHg |
Purity: | 97.0 % |
Density: | 1.348 g/cm3 |
MDL: | MFCD00661308 |
LogP: | 0.95790 |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P312, P304+P340, P305+P351+P338, P312, P321, P322, P330, P332+P313, P337+P313, P362, P363, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2021177330-A1 | Fused tricyclic compound and medicinal use thereof | 20200304 |
WO-2021169990-A1 | Kras inhibitors for treating cancers | 20200224 |
US-2021236663-A1 | Compounds and probes for imaging huntingtin protein | 20191218 |
WO-2021121276-A1 | Fused tetracyclic derivative, preparation method therefor, and medical use thereof | 20191217 |
US-2021188827-A1 | Atm kinase inhibitors and compositions and methods of use thereof | 20191204 |
PMID | Publication Date | Title | Journal |
32945666 | 20201022 | Synthesis and Structure-Activity Relationship of Dual-Stage Antimalarial Pyrazolo[3,4-b]pyridines | Journal of medicinal chemistry |
22825562 | 20120907 | Au(I)-catalyzed and iodine-mediated cyclization of enynylpyrazoles to provide pyrazolo[1,5-a]pyridines | Organic & biomolecular chemistry |
21723178 | 20120101 | Ultrasound assisted one-pot, three-components synthesis of pyrimido[1,2-a]benzimidazoles and pyrazolo[3,4-b]pyridines: A new access via phenylsulfone synthon | Ultrasonics sonochemistry |
21733750 | 20111015 | Synthesis, X-ray crystal structure and fluorescent spectra of novel pyrazolo[1,5-a]pyrazin-4(5H)-one derivatives | Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy |
21764304 | 20110915 | Phosphodiesterase inhibitors. Part 2: design, synthesis, and structure-activity relationships of dual PDE3/4-inhibitory pyrazolo[1,5-a]pyridines with anti-inflammatory and bronchodilatory activity | Bioorganic & medicinal chemistry letters |
Complexity: | 105 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 119.048347172 |
Formal Charge: | 0 |
Heavy Atom Count: | 9 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 119.048347172 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 41.6 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 0.5 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Pyridines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS